Private Label Tranexamic Acid Body Lotion Manufacturer

Minimum order quantities for private label tranexamic acid body lotion depend on whether you choose a white-label stock formula or a fully custom development path. White-label manufacturers — those who already have a validated TXA lotion base you simply rebrand — typically accept MOQs of 200 to 500 units. Semi-custom manufacturers, who modify an existing base to adjust TXA percentage, fragrance, or skin-feel, generally require 500 to 1,000 units. Fully custom formulation, where a cosmetic chemist builds your lotion from scratch to your exact specification, usually starts at 1,000 to 2,500 units because the development cost must be amortized across a larger run. Several factors push MOQ higher. If you require specialty packaging — airless pumps with a specific neck finish, a custom bottle mold, or FSC-certified tubes — the packaging supplier's own MOQ often becomes the binding constraint, not the filling line. Similarly, if your formula calls for a high-purity pharmaceutical-grade tranexamic acid source rather than a cosmetic-grade raw material, the ingredient supplier may have a minimum purchase of 1 kg or more, which itself dictates batch size. Geography also plays a role. Manufacturers based in South Korea and Taiwan, where TXA has been widely used in cosmetics for over a decade, often accept lower MOQs (as few as 200 units) because they run mixed batches efficiently. US-based manufacturers with dedicated cosmetic GMP suites tend to set floor minimums at 500 to 1,000 units to cover setup and cleaning validation costs. A common mistake founders make is negotiating the unit MOQ without asking about the minimum batch weight. A manufacturer might agree to 300 units of a 250 mL lotion, but their filling line minimum is 50 kg of finished product — run the math to make sure the numbers align before signing. At reorder, most manufacturers drop their effective MOQ for existing validated formulas because development and stability costs are already sunk. Reorder MOQs of 150 to 300 units are not uncommon for established accounts. AJ Cosmo Labs' iOS app lets you filter supplier listings by MOQ range so you only see manufacturers who can realistically serve your current production volume. Post your brief with your target unit count and let vetted cosmetic co-packers propose competitive terms.

The total cost to private label a tranexamic acid body lotion has several components that founders often undercount: formulation development, raw materials, filling and labor, packaging, testing, regulatory documentation, and logistics. Formulation development fees for a custom TXA lotion range from $1,500 to $8,000 depending on formula complexity, number of prototype iterations, and whether the manufacturer charges separately for stability testing. White-label programs typically waive development fees because the formula is pre-validated. Cost per finished unit at the filling stage breaks down roughly as follows. At 200–500 units, expect $4 to $9 per unit for a white-label program or $8 to $14 for semi-custom. At 1,000–2,500 units, fully custom formulas often land at $10 to $20 per unit. At 5,000+ units, blended cost including packaging typically falls to $3.50 to $8.00 per unit depending on bottle format. Transexamic acid itself is not a cheap raw material. Cosmetic-grade TXA sourced from reputable suppliers runs approximately $25 to $60 per kilogram. A 250 mL lotion at 3% TXA concentration contains roughly 7.5 grams of active ingredient per bottle, so TXA raw material alone adds $0.19 to $0.45 per unit at scale — modest, but meaningful at low MOQ. Packaging is frequently the largest variable. A simple HDPE squeeze bottle with a flip-top cap might cost $0.35 to $0.80 per unit. An airless pump in a frosted PET or glass bottle can run $1.80 to $4.50 per unit. Custom molds for proprietary bottle shapes require $3,000 to $15,000 in tooling investment before a single unit is filled. Third-party testing — including challenge test (preservative efficacy), heavy metals panel, and stability study — adds $800 to $3,500 per formula SKU, a one-time cost that amortizes across your production history. A realistic all-in budget for a first run of 500 units of a semi-custom TXA body lotion in a stock airless pump, including development, testing, filling, labeling, and domestic freight, is $6,000 to $12,000. Plan for 20–30% cost reduction at your second run once development costs are retired. Use the AJ Cosmo Labs iPhone app to post your brief and receive itemized quotes from multiple manufacturers simultaneously so you can compare cost structures line by line rather than accepting the first proposal.

Lead time for a private label tranexamic acid body lotion follows a predictable sequence of stages, each with its own duration that compounds into a total timeline. For a white-label program where you're applying your brand to a pre-existing, already-stable TXA lotion formula, the timeline is the shortest: 4 to 8 weeks. This covers label artwork review, compliance copy approval, filling scheduling, and outbound logistics. The formula is already validated, so no stability work is needed on your end. For a semi-custom or fully custom formula, the timeline expands significantly. Brief submission and cosmetic chemist assignment takes 1 to 2 weeks. Bench formulation and internal testing takes 2 to 4 weeks. First prototype production and shipment to you for review takes 1 to 2 weeks. Sensory evaluation, feedback, and one or two revision rounds add another 2 to 4 weeks. Accelerated stability testing at 45°C and 75% relative humidity runs a mandatory minimum of 8 weeks, though 12 weeks is standard before many retailers will accept the product. Packaging procurement — especially if you're ordering custom components from Asia — runs 8 to 14 weeks and often overlaps with formula development. Final production, QC, and Certificate of Analysis issuance add 2 to 3 weeks. All-in, a fully custom TXA body lotion from signed contract to finished goods in a US warehouse typically takes 16 to 24 weeks. Planning for 20 weeks as a base case is prudent for most indie founders. Two timeline killers that catch first-timers off guard: (1) back-and-forth on label compliance copy, especially if you're making any structure/function claims about skin brightening or hyperpigmentation that require legal review; and (2) delays in sourcing tranexamic acid raw material from a COA-verified supplier, which can add 2 to 4 weeks if the manufacturer's preferred TXA supplier is backordered. If you're targeting a specific retail or DTC launch date, work backward from that date and add a 4-week buffer for shipping delays and unexpected iterations. AJ Cosmo Labs connects you with manufacturers who publish their current production queue availability, so you can see upfront whether a supplier can realistically hit your timeline before you commit.

The effective and cosmetically accepted concentration range for tranexamic acid in leave-on body lotions is 2% to 5% by weight. Within that band, the choice of concentration depends on your target claims, regulatory market, and skin-sensitivity positioning. At 2%, TXA contributes to a skin-brightening and tone-evening effect suitable for sensitive skin positioning and for markets where you want to keep the formula firmly in cosmetic (not drug) territory. Clinical studies that first established TXA's efficacy for melasma used topical concentrations of 2% to 3%, providing a literature foundation for cosmetic structure/function language like "helps reduce the appearance of dark spots." At 3% to 5%, the formula is typically positioned for targeted hyperpigmentation concerns — post-inflammatory marks, sun spots, or uneven body tone — and is more common in premium or clinical-brand positioning. Some manufacturers have experience with TXA up to 5% in leave-on formats with well-tolerated safety profiles, but you should request your manufacturer's internal safety data at your chosen concentration before proceeding. Exceeding 5% in a cosmetic leave-on is uncommon and enters a gray area. Tranexamic acid was originally a pharmaceutical hemostatic agent; very high topical concentrations could attract regulatory scrutiny regarding drug vs. cosmetic classification in the US (FDA) and EU. In South Korea, where TXA in cosmetics is long-established, concentrations up to 2% are explicitly recognized in the functional cosmetics framework, and formulators there have extensive data at 2–3%. Formula pH is as important as concentration. TXA is most stable and efficacious between pH 5.5 and 7.0. Outside this range, both potency and physical stability can be compromised. Confirm your manufacturer's target pH range and request pH-at-fill and pH-after-stability data. Pairing matters too. TXA synergizes well with niacinamide (5–10%), kojic acid (below 1% in most markets), vitamin C derivatives, and alpha-arbutin for a multi-pathway brightening approach. Your cosmetic chemist can advise on combinations that are both efficacious and stable without creating compatibility issues in the emulsion. AJ Cosmo Labs hosts cosmetic chemists and formulators on its platform who specialize in actives-forward skincare and can advise on concentration and pairing strategy before you commit to a production run. Download the app to start that conversation.

Finding a vetted, low-MOQ tranexamic acid body lotion manufacturer requires more than a Google search or a trip to a trade show directory. The challenge is that TXA is a more technically demanding active than basic emollients — not every contract manufacturer has experience with it, and a low-MOQ manufacturer with no TXA track record is a significant formulation and stability risk. Start by defining your brief with enough specificity that manufacturers can self-select accurately. Include your target TXA percentage, packaging format, fill volume, target pH, fragrance preference (or fragrance-free), any claim restrictions (e.g., no drug claims), certifications required (cruelty-free, vegan, ISO 22716), and your unit MOQ. Vague briefs attract generalist manufacturers who may overbid or underdeliver on actives expertise. Vetting criteria should include: (1) ISO 22716 GMP certification — this is non-negotiable for any manufacturer supplying retail or e-commerce channels; (2) demonstrated experience with TXA or comparable water-soluble actives like niacinamide, kojic acid, or alpha-arbutin at meaningful concentrations; (3) in-house or contracted stability testing capability with documented protocols; (4) ability to provide a Certificate of Analysis for the TXA raw material including heavy metals and assay results; and (5) references from other indie brands at comparable MOQs — a manufacturer who has only run 50,000-unit batches will not serve a 300-unit client well operationally. Geographic options worth exploring: US-based contract manufacturers (higher cost, easier communication and regulatory alignment, lower shipping risk), South Korean ODM/OEM manufacturers (lower cost, deep TXA experience, but 12–16 week ocean freight adds to timeline and MOQ minimums vary widely), and EU-based manufacturers (ideal if EU is your primary market, CPNP compliance handled more smoothly). Red flags to avoid: manufacturers who cannot or will not share the full INCI list before signing an NDA; manufacturers who quote stability data without specifying the test conditions; and manufacturers who promise custom formula development at 100-unit MOQ — at that scale, development cost economics simply don't work unless they're using a stock base with minimal modification. AJ Cosmo Labs was built specifically to solve this search problem. The iOS app lets you post a structured product brief and receive responses from ISO-certified cosmetic manufacturers who have been pre-screened by the platform. You can filter by MOQ, certifications, and geography, message suppliers directly, track sample approvals, and make escrowed milestone payments — all in one place. Download AJ Cosmo Labs on the App Store to post your TXA lotion brief and connect with qualified manufacturers within days, not months.

Tranexamic acid body lotion sold in the United States does not require pre-market FDA approval when it is positioned and labeled as a cosmetic. Cosmetics in the US are regulated under the Federal Food, Drug, and Cosmetic Act and, since 2023, under the Modernization of Cosmetics Regulation Act (MoCRA) — neither of which requires pre-market approval. However, there are important compliance requirements and a critical classification boundary that every brand owner must understand. Under MoCRA, effective for most brands by July 2024, you must (1) register your manufacturing or processing facility with the FDA and (2) submit a product listing for each cosmetic product you introduce to the US market. These are not approvals — the FDA does not review or sign off on the formulas — but failure to comply is a prohibited act that can result in Warning Letters, import alerts, or product recalls. Your contract manufacturer may handle facility registration on their end, but product listing is the brand owner's responsibility. The classification line to watch: if your marketing language implies that the lotion treats, cures, or prevents a disease or alters a physiological function, FDA may deem it a drug rather than a cosmetic. For TXA body lotions, safe cosmetic claim territory includes phrases like "helps reduce the appearance of dark spots," "evens skin tone," and "visibly brightens." Problematic language includes "treats hyperpigmentation," "inhibits melanin production" (mechanistic drug-like claim), or any reference to a medical condition. Your cosmetic chemist and a regulatory consultant should review all label and marketing copy before launch. For the EU, the regulatory framework is stricter. Tranexamic acid is not currently on the EU Cosmetics Regulation Annex III (restricted substances) or Annex II (prohibited substances) list, meaning it is permissible but must be substantiated for safety by a qualified cosmetic safety assessor in a Product Information File. A Responsible Person must be appointed within the EU, and the product must be notified through the CPNP before it goes on sale. Your EU-market lotion must also carry a Period After Opening (PAO) symbol and full EU-compliant labeling. For Canada (Health Canada), TXA in cosmetics falls under the Cosmetics Regulations; a Cosmetic Notification must be filed within 10 days of first sale. For the UK post-Brexit, the UK Cosmetics Regulation (retained EU law) applies, requiring a separate UK Responsible Person and SCPN notification. The safest path is to work with a contract manufacturer experienced in multi-market regulatory compliance. AJ Cosmo Labs' vetted manufacturer network includes suppliers who can guide you through MoCRA listing, EU CPNP notification, and Health Canada filing simultaneously. Download the app to connect with manufacturers who have cross-market compliance experience.

Yes, you can absolutely have a fully custom tranexamic acid body lotion formula developed and sold under your brand name — this is the standard model for private label and OEM cosmetic manufacturing. Formula ownership, however, is one of the most consequential and most frequently misunderstood contractual points in the industry, and getting it wrong at the start can lock your brand into a single supplier indefinitely. In a white-label arrangement, the manufacturer owns the formula. You are licensed to sell finished product under your brand, but you cannot take the formula to another manufacturer if you want to switch suppliers, change pricing, or scale up. This is fine for early-stage validation but is a strategic liability for a growing brand. In a semi-custom arrangement, formula ownership terms vary. Some manufacturers retain ownership but grant an exclusivity window — typically 12 to 24 months — during which they won't sell the same base to a direct competitor. After the window, or if you miss purchase minimums, the formula may revert to their portfolio. Always read the exclusivity clause carefully. In a fully custom arrangement where your brand pays a development fee, formula ownership should transfer to you upon payment completion. This must be explicit in the contract: the IP assignment clause should state that all formulation IP, including the full INCI list, batch records, and manufacturing methodology, transfers irrevocably to the brand upon final payment. Many manufacturers will try to retain the manufacturing trade secret (the specific process parameters, temperature profiles, and blending sequence) even when ceding formula ownership — this is a legitimate position, but it means your new manufacturer will need to re-optimize the process, which takes time and may result in minor formula changes. Protect yourself with a well-drafted NDA and Supply Agreement before sharing any proprietary information. The agreement should cover: formula IP ownership, exclusivity terms and duration, minimum purchase obligations triggering that exclusivity, what happens to existing inventory and stability data if you switch manufacturers, and confidentiality obligations that survive contract termination. For TXA-specific concerns: if your manufacturer sources their tranexamic acid from a single supplier and that sourcing is embedded in the formula as a spec, switching manufacturers may require requalifying the raw material — a step that adds 4 to 8 weeks and modest cost to a transfer process. AJ Cosmo Labs recommends that every brand owner using the platform consult a cosmetic industry attorney to review supply agreements before signing, especially for fully custom development. The app facilitates direct messaging with manufacturers so you can ask formula ownership questions early in the conversation, before you invest in development fees. Download AJ Cosmo Labs on the App Store to start vetting manufacturers who clearly disclose their IP terms upfront.